tert-butyl 3-(1-hydroxy-3,6,9,12,15,18-hexaoxahenicos-20-yn-21-yl)-1H-indazole-1-carboxylate

Catalog No.: 
ACSOSS357
CAS No.: 
-
Molecular Formula: 
C27H40N2O9
Molecular Weight: 
536.62
tert-butyl 3-(1-hydroxy-3,6,9,12,15,18-hexaoxahenicos-20-yn-21-yl)-1H-indazole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$350.00InquiryInquiry
250mg95%$700.00InquiryInquiry
1g95%$1901.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 3-(1-hydroxy-3,6,9,12,15,18-hexaoxahenicos-20-yn-21-yl)-1H-indazole-1-carboxylate
IUPAC Nametert-butyl 3-(1-hydroxy-3,6,9,12,15,18-hexaoxahenicos-20-yn-21-yl)-1H-indazole-1-carboxylate
Molecular FormulaC27H40N2O9
Molecular Weight536.62
SMILESCC(C)(C)OC(=O)N1N=[C:1](C#CCOCCOCCOCCOCCOCCOCCO)C2=CC=CC=C21
InChI KeyOIDRRANNXPKDJU-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACSOSS357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFDIU712 route compound structure diagram
    ACFDIU712944560-99-0In Stock
  2. Plus
  3. ACEDAL631 route compound structure diagram
    ACEDAL631290368-00-2In Stock
  4. Then
  5. ACSOSS357 route product structure diagram
    ACSOSS357-
Inquiry

2. ACSOSS357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFDIU712 route compound structure diagram
    ACFDIU712944560-99-0In Stock
  2. Plus
  3. ACITRC620 route compound structure diagram
    ACITRC6201257296-40-4In Stock
  4. Then
  5. ACSOSS357 route product structure diagram
    ACSOSS357-
Inquiry

3. ACSOSS357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYMUC749 route compound structure diagram
    ACYMUC7491036204-60-0In Stock
  2. Plus
  3. ACEDAL631 route compound structure diagram
    ACEDAL631290368-00-2In Stock
  4. Then
  5. ACSOSS357 route product structure diagram
    ACSOSS357-
Inquiry

Comments (0)